Jesse Lyons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jesse Lyons has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Douglas A. Lauffenburger
Department of Biological Engineering, Massachusetts Institute of Technology
2 shared publications - Ken S. Lau
Vanderbilt Epithelial Biology Center, Vanderbilt University Medical Center, Nashville, USA
2 shared publications - Kevin M. Haigis
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA
2 shared publications Abigail L Miller
1 shared publicationAlan J. Simmons
Epithelial Biology Center
1 shared publication- Amanda Edwards
Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA
1 shared publication
Latest Publications
- Open Access
- 27 February 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 11 (519)
Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis
A combination of transcriptomics, proteomics, and phosphoproteomics reveals therapeutic targets in colitis.
- 27 February 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 11 (519)
Open AccessIntegrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis
A combination of transcriptomics, proteomics, and phosphoproteomics reveals therapeutic targets in colitis.
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S382-S383
Sa1857 New Targets of Interest: MIP-1a and MIP-1b in Crohn's Disease
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S382-S383
Sa1857 New Targets of Interest: MIP-1a and MIP-1b in Crohn's Disease
- Open Access
- 10 June 2015
- Published by Elsevier in Stem Cell Research
- Vol. 15 (1) , 165-171
Oncogenic K-Ras promotes proliferation in quiescent intestinal stem cells
- 10 June 2015
- Published by Elsevier in Stem Cell Research
- Vol. 15 (1) , 165-171
Open AccessOncogenic K-Ras promotes proliferation in quiescent intestinal stem cells
- 1 January 2015
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 7 (7) , 740-757
Multiscale analysis of the murine intestine for modeling human diseases
When functioning properly, the intestine is one of the key interfaces between the human body and its environment.
- 1 January 2015
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 7 (7) , 740-757
Multiscale analysis of the murine intestine for modeling human diseases
When functioning properly, the intestine is one of the key interfaces between the human body and its environment.
- 20 August 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (34) , 13845-13850
MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells
The melanocortin 1 receptor (MC1R) mediates the tanning response through induction of cAMP and downstream pigmentary enzymes. Diminished function alleles of MC1R are associated with decreased tanning and increased melanoma risk, which has been attributed to increased rates of mutation. We have found that MC1R or cAMP signaling also directly decreases proliferation in melanoma cell lines. MC1R overexpression, treatment with the MC1R ligand, or treatment with small-molecule activators of cAMP signaling causes delayed progression from G2 into mitosis. This delay is caused by phosphorylation and inhibition of cdc25B, a cyclin dependent kinase 1-activating phosphatase, and is rescued by expression of a cdc25B mutant that cannot be phosphorylated at the serine 323 residue. These results show that MC1R and cAMP signaling can directly inhibit melanoma growth through regulation of the G2/M checkpoint.
- 20 August 2013
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (34) , 13845-13850
MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells
The melanocortin 1 receptor (MC1R) mediates the tanning response through induction of cAMP and downstream pigmentary enzymes. Diminished function alleles of MC1R are associated with decreased tanning and increased melanoma risk, which has been attributed to increased rates of mutation. We have found that MC1R or cAMP signaling also directly decreases proliferation in melanoma cell lines. MC1R overexpression, treatment with the MC1R ligand, or treatment with small-molecule activators of cAMP signaling causes delayed progression from G2 into mitosis. This delay is caused by phosphorylation and inhibition of cdc25B, a cyclin dependent kinase 1-activating phosphatase, and is rescued by expression of a cdc25B mutant that cannot be phosphorylated at the serine 323 residue. These results show that MC1R and cAMP signaling can directly inhibit melanoma growth through regulation of the G2/M checkpoint.
- Open Access
- 1 January 2013
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 5 (11) , 1355-1365
Network analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α
Tumor necrosis factor alpha (TNF-α) is an inflammatory cytokine that can elicit distinct cellular behaviors under different molecular contexts. Mitogen activated protein kinase (MAPK) pathways, especially the extracellular signal-regulated kinase (Erk) pathway, help to integrate influences from the environmental context, and therefore modulate the phenotypic effect of TNF-α exposure. To test how variations in flux through the Erk pathway modulate TNF-α-elicited phenotypes in a complex physiological environment, we exposed mice with different Ras mutations (K-Ras activation, N-Ras activation, and N-Ras ablation) to TNF-α and observed phenotypic and signaling changes in the intestinal epithelium. Hyperactivation of Mek1, an Erk kinase, was observed in the intestine of mice with K-Ras activation and, surprisingly, in N-Ras null mice. Nevertheless, these similar Mek1 outputs did not give rise to the same phenotype, as N-Ras null intestine was hypersensitive to TNF-α-induced intestinal cell death while K-Ras mutant intestine was not. A systems biology approach applied to sample the network state revealed that the signaling contexts presented by these two Ras isoform mutations were different. Consistent with our experimental data, N-Ras ablation induced a signaling network state that was mathematically predicted to be pro-death, while K-Ras activation did not. Further modeling by constrained Fuzzy Logic (cFL) revealed that N-Ras and K-Ras activate the signaling network with different downstream distributions and dynamics, with N-Ras effects being more transient and diverted more towards PI3K-Akt signaling and K-Ras effects being more sustained and broadly activating many pathways. Our study highlights the necessity to consider both environmental and genomic contexts of signaling pathway activation in dictating phenotypic responses, and demonstrates how modeling can provide insight into complex in vivo biological mechanisms, such as the complex interplay between K-Ras and N-Ras in their downstream effects.
- 1 January 2013
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 5 (11) , 1355-1365
Open AccessNetwork analysis of differential Ras isoform mutation effects on intestinal epithelial responses to TNF-α
Tumor necrosis factor alpha (TNF-α) is an inflammatory cytokine that can elicit distinct cellular behaviors under different molecular contexts. Mitogen activated protein kinase (MAPK) pathways, especially the extracellular signal-regulated kinase (Erk) pathway, help to integrate influences from the environmental context, and therefore modulate the phenotypic effect of TNF-α exposure. To test how variations in flux through the Erk pathway modulate TNF-α-elicited phenotypes in a complex physiological environment, we exposed mice with different Ras mutations (K-Ras activation, N-Ras activation, and N-Ras ablation) to TNF-α and observed phenotypic and signaling changes in the intestinal epithelium. Hyperactivation of Mek1, an Erk kinase, was observed in the intestine of mice with K-Ras activation and, surprisingly, in N-Ras null mice. Nevertheless, these similar Mek1 outputs did not give rise to the same phenotype, as N-Ras null intestine was hypersensitive to TNF-α-induced intestinal cell death while K-Ras mutant intestine was not. A systems biology approach applied to sample the network state revealed that the signaling contexts presented by these two Ras isoform mutations were different. Consistent with our experimental data, N-Ras ablation induced a signaling network state that was mathematically predicted to be pro-death, while K-Ras activation did not. Further modeling by constrained Fuzzy Logic (cFL) revealed that N-Ras and K-Ras activate the signaling network with different downstream distributions and dynamics, with N-Ras effects being more transient and diverted more towards PI3K-Akt signaling and K-Ras effects being more sustained and broadly activating many pathways. Our study highlights the necessity to consider both environmental and genomic contexts of signaling pathway activation in dictating phenotypic responses, and demonstrates how modeling can provide insight into complex in vivo biological mechanisms, such as the complex interplay between K-Ras and N-Ras in their downstream effects.
- Open Access
- 31 March 2003
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 197 (7) , 861-874
Combined Deficiency of p50 and cRel in CD4+ T Cells Reveals an Essential Requirement for Nuclear Factor κB in Regulating Mature T Cell Survival and In Vivo Function
Signaling pathways involved in regulating T cell proliferation and survival are not well understood. Here we have investigated a possible role of the nuclear factor (NF)-κB pathway in regulating mature T cell function by using CD4+ T cells from p50−/− cRel−/− mice, which exhibit virtually no inducible κB site binding activity. Studies with these mice indicate an essential role of T cell receptor (TCR)-induced NF-κB in regulating interleukin (IL)-2 expression, cell cycle entry, and survival of T cells. Our results further indicate that NF-κB regulates TCR-induced expression of antiapoptotic Bcl-2 family members. Strikingly, retroviral transduction of CD4+ T cells with the NF-κB–inducing IκB kinase β showed that NF-κB activation is not only necessary but also sufficient for T cell survival. In contrast, our results indicate a lack of involvement of NF-κB in both IL-2 and Akt-induced survival pathways. In vivo, p50−/− cRel−/− mice showed impaired superantigen-induced T cell responses as well as decreased numbers of effector/memory and regulatory CD4+ T cells. These findings provide the first demonstration of a role for NF-κB proteins in regulating T cell function in vivo and establish a critically important function of NF-κB in TCR-induced regulation of survival.
- 31 March 2003
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 197 (7) , 861-874
Open AccessCombined Deficiency of p50 and cRel in CD4+ T Cells Reveals an Essential Requirement for Nuclear Factor κB in Regulating Mature T Cell Survival and In Vivo Function
Signaling pathways involved in regulating T cell proliferation and survival are not well understood. Here we have investigated a possible role of the nuclear factor (NF)-κB pathway in regulating mature T cell function by using CD4+ T cells from p50−/− cRel−/− mice, which exhibit virtually no inducible κB site binding activity. Studies with these mice indicate an essential role of T cell receptor (TCR)-induced NF-κB in regulating interleukin (IL)-2 expression, cell cycle entry, and survival of T cells. Our results further indicate that NF-κB regulates TCR-induced expression of antiapoptotic Bcl-2 family members. Strikingly, retroviral transduction of CD4+ T cells with the NF-κB–inducing IκB kinase β showed that NF-κB activation is not only necessary but also sufficient for T cell survival. In contrast, our results indicate a lack of involvement of NF-κB in both IL-2 and Akt-induced survival pathways. In vivo, p50−/− cRel−/− mice showed impaired superantigen-induced T cell responses as well as decreased numbers of effector/memory and regulatory CD4+ T cells. These findings provide the first demonstration of a role for NF-κB proteins in regulating T cell function in vivo and establish a critically important function of NF-κB in TCR-induced regulation of survival.